Andrographolide Ameliorates Inflammation and Fibrogenesis and Attenuates Inflammasome Activation in Experimental Non-Alcoholic Steatohepatitis
Abstract Therapy for nonalcoholic steatohepatitis (NASH) is limited. Andrographolide (ANDRO), a botanical compound, has a potent anti-inflammatory activity due to its ability to inhibit NF-κB. ANDRO has been also shown to inhibit the NLRP3 inflammasome, a relevant pathway in NASH. Our aim was to eva...
Enregistré dans:
Auteurs principaux: | Daniel Cabrera, Alexander Wree, Davide Povero, Nancy Solís, Alejandra Hernandez, Margarita Pizarro, Han Moshage, Javiera Torres, Ariel E. Feldstein, Claudio Cabello-Verrugio, Enrique Brandan, Francisco Barrera, Juan Pablo Arab, Marco Arrese |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/bd86bebf1d174a5fad6317ffa6d68f10 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Fibrogenesis & tissue repair
Publié: (2008) -
β-glycosphingolipids ameliorated non-alcoholic steatohepatitis in the Psammomys obesus model
par: Zigmond E, et autres
Publié: (2014) -
Clodronate, an inhibitor of the vesicular nucleotide transporter, ameliorates steatohepatitis and acute liver injury
par: Nao Hasuzawa, et autres
Publié: (2021) -
Attenuation of Innate Immunity by Andrographolide Derivatives Through NF-κB Signaling Pathway
par: Xin Nie, et autres
Publié: (2017) -
Engineered andrographolide nanosystems for smart recovery in hepatotoxic conditions
par: Roy P, et autres
Publié: (2014)